The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Mon., Oct. 3, 2:47 PM

Slide #2. Avenue Therapeutics, Inc. (NASDAQ:ATXI) 1 for 15 Reverse Split

Announced: 9/22/2022
Stock Split: 1 for 15
Record Date: 9/22/2022
Pay Date: 9/23/2022
ATXI Optionable?: No

Avenue Therapeutics is a pharmaceutical company that develop and commercialize its product principally for use in the acute/intensive care hospital setting. Co.'s product candidate is intravenous (IV) Tramadol, for the treatment of post-operative acute pain. Tramadol, a synthetic dual-acting opioid, is a centrally acting analgesic with weak opioid agonist properties. It also works via the inhibition of serotonin and noradrenaline re-uptake and blocking nociceptive impulses at the spinal level. Co. has completed a pharmacokinetic study for IV Tramadol in healthy volunteers. Co. also has initiated a Phase 3 development program of IV Tramadol for the management of post-operative pain.
ATXI Detailed Information Page & Split History »

Company Name: 
Avenue Therapeutics Inc
Drugs & Pharmaceuticals
Number of ETFs Holding ATXI: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the ATXI Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree ATXI Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)

Analysts' Target Price:
ATXI Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Stock Splits Page |

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.